Trials / Unknown
UnknownNCT02806804
Safety and Immunogenicity Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged Years 3-60
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 2,400 (estimated)
- Sponsor
- Beijing Chaoyang District Centre for Disease Control and Prevention · Academic / Other
- Sex
- All
- Age
- 3 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the safety and immunogenicity of the quadrivalent influenza virus vaccine in healthy people aged years 3-60.Subjects will be randomly divided into 3 groups,receiving the test vaccine, commercially available trivalent influenza vaccine and trivalent influenza vaccine containing new influenza B component respectively. Each group has 800 subjects,2400 in total.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | one dose test vaccine | |
| BIOLOGICAL | one dose commercially available trivalent influenza vaccine | |
| BIOLOGICAL | One dose of Quadrivalent Influenza Virus Vaccine |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2016-06-01
- First posted
- 2016-06-21
- Last updated
- 2016-06-21
Source: ClinicalTrials.gov record NCT02806804. Inclusion in this directory is not an endorsement.